{"DataElement":{"publicId":"4986325","version":"1","preferredName":"Duodenum/Ampulla/Jejunum/Ileum Neuroendocrine Tumor American Joint Committee on Cancer (AJCC) Edition 7 Clinical Distant Metastasis M Stage","preferredDefinition":"Extent of the distant metastasis for the duodenum/ampulla/jejunum/ileum neuroendocrine tumor based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"4985467v1.0:4986102v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"4985467","version":"1","preferredName":"Digestive System Neuroendocrine Neoplasm Clinical M Stage","preferredDefinition":"A neoplasm with neuroendocrine differentiation arising from the digestive system.  It includes neuroendocrine tumors (well-differentiated endocrine tumors or carcinoid tumors and well differentiated endocrine carcinomas) and neuroendocrine carcinomas (poorly differentiated neuroendocrine carcinomas, small cell carcinomas, and large cell neuroendocrine carcinomas)._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system.  M refers to the presence of metastasis.","longName":"4985461v1.0:2207806v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"4985461","version":"1","preferredName":"Digestive System Neuroendocrine Neoplasm","preferredDefinition":"A neoplasm with neuroendocrine differentiation arising from the digestive system.  It includes neuroendocrine tumors (well-differentiated endocrine tumors or carcinoid tumors and well differentiated endocrine carcinomas) and neuroendocrine carcinomas (poorly differentiated neuroendocrine carcinomas, small cell carcinomas, and large cell neuroendocrine carcinomas).","longName":"C27721","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Digestive System Neuroendocrine Neoplasm","conceptCode":"C27721","definition":"A neoplasm with neuroendocrine differentiation arising from the digestive system. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2B1F3A-D181-5724-E050-BB89AD435649","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207806","version":"1","preferredName":"Clinical M Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25398:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30E1-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2B5679-D721-666E-E050-BB89AD4303B8","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created per request by COG for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4986102","version":"1","preferredName":"Duodenum/Ampulla/Jejunum/Ileum Neuroendocrine Tumor American Joint Committee on Cancer (AJCC) Edition 7 Clinical M Stage","preferredDefinition":"A clinical finding about one or more characteristics of duodenum/ampulla/jejunum/ileum neuroendocrine tumor, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"4986102v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M0","valueDescription":"Duodenum/Ampulla/Jejunum/Ileum Neuroendocrine Tumor cM0 TNM Finding v7","ValueMeaning":{"publicId":"4986104","version":"1","preferredName":"Duodenum/Ampulla/Jejunum/Ileum Neuroendocrine Tumor cM0 TNM Finding v7","longName":"4986104","preferredDefinition":"Duodenum/ampulla/jejunum/ileum neuroendocrine tumor without evidence of distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Duodenum/Ampulla/Jejunum/Ileum Neuroendocrine Tumor cM0 TNM Finding v7","conceptCode":"C90128","definition":"Duodenum/ampulla/jejunum/ileum neuroendocrine tumor without evidence of distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7A32-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7A4B-308A-E050-BB89AD435DB5","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"M1","valueDescription":"Duodenum/Ampulla/Jejunum/Ileum Neuroendocrine Tumor cM1 TNM Finding v7","ValueMeaning":{"publicId":"4986106","version":"1","preferredName":"Duodenum/Ampulla/Jejunum/Ileum Neuroendocrine Tumor cM1 TNM Finding v7","longName":"4986106","preferredDefinition":"Duodenum/ampulla/jejunum/ileum neuroendocrine tumor with distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Duodenum/Ampulla/Jejunum/Ileum Neuroendocrine Tumor cM1 TNM Finding v7","conceptCode":"C90131","definition":"Duodenum/ampulla/jejunum/ileum neuroendocrine tumor with distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7A58-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7A71-308A-E050-BB89AD435DB5","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4986101","version":"1","preferredName":"Duodenum/Ampulla/Jejunum/Ileum Neuroendocrine Tumor Clinical Distant Metastasis TNM Finding v7 Stage","preferredDefinition":"A clinical finding about one or more characteristics of duodenum/ampulla/jejunum/ileum neuroendocrine tumor, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C90126:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Duodenum/Ampulla/Jejunum/Ileum Neuroendocrine Tumor Clinical Distant Metastasis TNM Finding v7","conceptCode":"C90126","definition":"A clinical finding about one or more characteristics of duodenum/ampulla/jejunum/ileum neuroendocrine tumor, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7A06-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7A17-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"COOPERM","dateModified":"2015-09-22","changeDescription":"Created per request by COG for their APEC14B1 study in Rave. mc 8/26/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"4985894","version":"1","longName":"Neuroendocrine","context":"NCIP"},{"publicId":"4985892","version":"1","longName":"Duodenum/Ampulla/Jejunum/Ileum","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777526","version":"1","longName":"Neuroendocrine ","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical M Stage","type":"Preferred Question Text","description":"Clinical M Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"1E3B406F-494C-408D-E050-BB89AD430537","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"TAYLORT","dateModified":"2017-04-19","changeDescription":"Created by COG request for their APEC14B1 study in Rave. mc 8/26/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}